BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36208272)

  • 1. [Clinical Observation of Neutropenia Patients with Hematonosis Treated with Polymyxin B Sulfate].
    Wu SQ; Zhan R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1596-1600. PubMed ID: 36208272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection].
    Zhou M; Kang HZ; Gu CY; Liu YJ; Wang Y; Miao M; Fu JH; Tang XW; Qiu HY; Fu CC; Jin ZM; Li CX; Chen SN; Sun AN; Wu DP; Han Y
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):484-489. PubMed ID: 37550204
    [No Abstract]   [Full Text] [Related]  

  • 3. Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study.
    Ma L; Shen J; Jiang H; Qian S; Zhang J; Lan J; Zhou H; Lang W; Mei C; Zhou X; Zhu L; Xu G; Ye L; Hu C; Ren Y; Yang X; Jin J; Ye X; Tong H
    J Infect; 2023 Apr; 86(4):406-409. PubMed ID: 36702310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical Analysis of Colistin Sulfate in the Treatment of Hematonosis Infected by Multidrug-Resistant Gram-Negative Bacteria].
    Wu YB; Jiang SS; Wu YX; Li DY; Li Q; Wang X; Liu B; Bao HY; Hu XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1878-1884. PubMed ID: 38071076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections.
    Xia GL; Jiang RL
    BMC Infect Dis; 2021 Oct; 21(1):1034. PubMed ID: 34607561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of sepsis with extensively drug resistant Gram-negative bacteria in intensive care unit treated with polymyxin B-based combination therapy].
    Zhao S; Yan L; Wang C; Peng M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):150-154. PubMed ID: 32274997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
    Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
    J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
    Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
    Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
    Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
    Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute Leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
    Gao HH; Yao ZL; Li Y; Huang S; Liu J; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):684-690. PubMed ID: 29950204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on intravenous combined with aerosol inhalation of polymyxin B for the treatment of pneumonia caused by multidrug-resistant Gram-negative bacteria].
    Zhou L; Li C; Weng Q; Wu J; Luo H; Xue Z; Xiao Y; Chen C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):416-420. PubMed ID: 34053483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
    Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
    Moriuchi Y; Kamihira S; Yamamura M; Mori H; Miyazaki Y; Tokunaga S; Nonaka H; Amagasaki T; Yamada Y; Yoshida Y
    Rinsho Ketsueki; 1990 Oct; 31(10):1664-9. PubMed ID: 2123946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment.
    Mattos KPH; Gouvêa IR; Quintanilha JCF; Cursino MA; Vasconcelos PENS; Moriel P
    J Clin Pharm Ther; 2019 Jun; 44(3):415-419. PubMed ID: 30666679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B-induced rhabdomyolysis: A case report.
    Ni M; Meng X; Wang L; Zhao Y; Yu M; Shi S
    Medicine (Baltimore); 2020 Oct; 99(43):e22924. PubMed ID: 33120846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-Resistant Gram-Negative Bacteria-Related Healthcare-Associated Ventriculitis and Meningitis: Antimicrobial Resistance of the Pathogens, Treatment, and Outcome.
    Ye Y; Kong Y; Ma J; Shi G
    Microbiol Spectr; 2022 Jun; 10(3):e0025322. PubMed ID: 35467409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.